Patients
A total of 543 patients were formally assessed for eligibility and enrolled. The median age was 35 (IQR, 26-49) years; 304 patients (56.0%) were female and 239 (44.0%) were male. Two hundred sixty-two patients were recommended for early COVID-19 vaccination and 281 for deferred vaccination. The baseline characteristics were similar between 2 groups (